These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15552996)

  • 1. [Role of perlecan in neuromuscular function: studies in knockout mice and human disorders].
    Hirasawa E
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2425-30. PubMed ID: 15552996
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of perlecan in skeletal development and diseases.
    Hassell J; Yamada Y; Arikawa-Hirasawa E
    Glycoconj J; 2002; 19(4-5):263-7. PubMed ID: 12975604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
    Stum M; Girard E; Bangratz M; Bernard V; Herbin M; Vignaud A; Ferry A; Davoine CS; Echaniz-Laguna A; René F; Marcel C; Molgó J; Fontaine B; Krejci E; Nicole S
    Hum Mol Genet; 2008 Oct; 17(20):3166-79. PubMed ID: 18647752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.
    Arikawa-Hirasawa E; Rossi SG; Rotundo RL; Yamada Y
    Nat Neurosci; 2002 Feb; 5(2):119-23. PubMed ID: 11802174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schwartz-Jampel syndrome(chondrodystrophic myotonia)].
    Arikawa-Hirasawa E
    Ryoikibetsu Shokogun Shirizu; 2001; (35):126-9. PubMed ID: 11555888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Roles of perlecan in development and disease: studies in knockout mice and human disorders].
    Arikawa-Hirasawa E; Yamada Y
    Seikagaku; 2001 Oct; 73(10):1257-61. PubMed ID: 11725543
    [No Abstract]   [Full Text] [Related]  

  • 8. Schwartz-Jampel syndrome and perlecan deficiency.
    Stum M; Davoine CS; Fontaine B; Nicole S
    Acta Myol; 2005 Oct; 24(2):89-92. PubMed ID: 16550923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models.
    Gomes RR; Farach-Carson MC; Carson DD
    Cells Tissues Organs; 2004; 176(1-3):79-86. PubMed ID: 14745237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on molecules: perlecan (HSPG2).
    Smith S; Hassell JR
    Exp Eye Res; 2006 Sep; 83(3):471-2. PubMed ID: 16549064
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparan sulfate: lessons from knockout mice.
    Forsberg E; Kjellén L
    J Clin Invest; 2001 Jul; 108(2):175-80. PubMed ID: 11457868
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and functional organization of synaptic acetylcholinesterase.
    Aldunate R; Casar JC; Brandan E; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
    Rodgers KD; Sasaki T; Aszodi A; Jacenko O
    Hum Mol Genet; 2007 Mar; 16(5):515-28. PubMed ID: 17213231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.
    Echaniz-Laguna A; Rene F; Marcel C; Bangratz M; Fontaine B; Loeffler JP; Nicole S
    Muscle Nerve; 2009 Jul; 40(1):55-61. PubMed ID: 19367640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of the pericellular matrix molecule perlecan lowers in situ cell and matrix stiffness in developing cartilage.
    Xu X; Li Z; Leng Y; Neu CP; Calve S
    Dev Biol; 2016 Oct; 418(2):242-7. PubMed ID: 27578148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate of perlecan is involved in glomerular filtration.
    Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
    J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance.
    Girard E; Barbier J; Chatonnet A; Krejci E; Molgó J
    Chem Biol Interact; 2005 Dec; 157-158():87-96. PubMed ID: 16274683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital disorders of neuromuscular transmission.
    Engel AG
    Semin Neurol; 1990 Mar; 10(1):12-26. PubMed ID: 2161125
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular transmission.
    J Assoc Physicians India; 1979 Sep; 27(9):815-6. PubMed ID: 44295
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions.
    Massoulié J; Millard CB
    Curr Opin Pharmacol; 2009 Jun; 9(3):316-25. PubMed ID: 19423392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.